Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage of oligonucleotides suitable for the treatment of tumors

Dosage of oligonucleotides suitable for the treatment of tumors

US Patent 8822425 · Granted Sep 2, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for selective oligonucleotide modification2015
Mixture comprising an inhibitor or suppressor of a gene and a molecule binding t2014
Method for stimulating the immune system2014
Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system2013
Method for inhibiting “melanoma inhibitory activity” MIA2012
Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment o2012
Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA2011
Antisense-oligonucleotides for the treatment of immuno-suppressive effects of tr2010
Antisense oligonucleotide preparation method2009
Pharmaceutical composition comprising antisense-nucleic acid for prevention and/2008
Antisense oligonucleotide preparation method2005
Antisense-oligonucleotides for transforming growth factor-&bgr; (TGF-&bgr;)2002